| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 462.34B | 486.80B | 468.24B | 494.74B | 655.26B |
| Gross Profit | 103.46B | 91.37B | 86.99B | 82.80B | 128.24B |
| EBITDA | 61.66B | 18.26B | 62.81B | 23.63B | 74.39B |
| Net Income | 23.87B | -4.82B | 28.98B | -7.03B | 24.50B |
Balance Sheet | |||||
| Total Assets | 946.31B | 865.67B | 789.03B | 732.68B | 837.95B |
| Cash, Cash Equivalents and Short-Term Investments | 55.83B | 115.97B | 36.36B | 31.18B | 79.49B |
| Total Debt | 358.17B | 330.54B | 213.43B | 218.10B | 241.81B |
| Total Liabilities | 491.38B | 453.66B | 359.68B | 351.05B | 443.92B |
| Stockholders Equity | 437.21B | 395.10B | 408.75B | 361.68B | 369.65B |
Cash Flow | |||||
| Free Cash Flow | -12.46B | -23.09B | 21.99B | -8.70B | -3.67B |
| Operating Cash Flow | 59.98B | 35.84B | 52.96B | 18.13B | 32.71B |
| Investing Cash Flow | -140.23B | -63.15B | -33.32B | -26.02B | -41.09B |
| Financing Cash Flow | 13.03B | 105.85B | -15.71B | 2.44B | 6.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥604.70B | 23.74 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥346.07B | 11.44 | 5.47% | 3.41% | 0.55% | 25.37% | |
67 Neutral | ¥321.14B | 13.48 | 1.47% | 4.29% | -5.02% | ― | |
67 Neutral | ¥371.78B | 16.75 | 9.45% | 2.65% | 1.87% | -5.06% | |
64 Neutral | ¥498.55B | 11.14 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥342.34B | 34.95 | 9.34% | 4.27% | -1.18% | -80.61% |